Inflammatory Bowel Disease in elderly patients: Clinical characteristics and management in a tertiary hospital
DOI:
https://doi.org/10.47892/rgp.2023.431.1444Keywords:
Inflammatory Bowel Diseases / therapy, Crohn Disease, Colitis, Ulcerative, AgedAbstract
Inflammatory bowel disease (IBD) in elderly patients is characterized by its clinical variability, different differential diagnoses and therapeutic management. The objective of our investigation is to evaluate the clinical characteristics and management of elderly patients with IBD. We developed an observational, descriptive, retrospective study from January 2011 to December 2019 in patients with IBD at the Gastroenterology Service of Guillermo Almenara Irigoyen National Hospital, Lima-Peru. 55 patients with CD and 107 with UC were evaluated; 45.6% of patients with IBD are older adults. Of these, 28 had CD and 46 UC. Older adults with CD presented predominantly an inflammatory phenotype and colonic location, while extensive and left-sided colitis were the most frequent in UC. Elderly patients had a lower CDAI score (279.8 vs 323.2) and a lower Mayo index (7.1 vs 9.2) in relation to the younger, without significant differences. Regarding treatment, a lower use of azathioprine (2 vs 8, p <0.03) and Anti-TNF (9 vs 18, p <0.01) was observed in the elderly with CD. The need for surgery and the frequency of post-surgical complications were similar between both groups. In conclusion, nearly half of IBD patients are older adults. The colonic location was the most frequent in CD, and in UC extensive and left colitis. We observed a lower use of azathioprine and biological therapy in elderly patients, without significant differences in the use of corticosteroids and aminosalicylates compared to younger people.
Downloads
Metrics
References
REFERENCIAS BIBLIOGRÁFICAS
Molodecky N, Soon I, Rabi D, Ghali W, Ferris M, Chernoff G et al. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology. 2012, 142(1), 46–54. doi:10.1053/j.gastro.2011.10.001
Shivashankar R, Tremaine W, Harmsen W, & Loftus E. Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010. Clinical Gastroenterology and Hepatology. 2017, 15(6), 857–863. doi:10.1016/j.cgh.2016.10.039
Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology. 2019;156(5):1345–1353.e1344. doi:10.1053/j.gastro.2019.01.002
Hussain S, Pardi D. Inflammatory Bowel Disease in the Elderly. Drugs & Aging 2010; 27, 617–624
Loftus E, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn`s disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence and survival. Gastroenterology. 1998; 114: 1161-1168.
Loftus E, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence and survival. Gut. 2000; 46: 336-343.
Ananthakrishnan AN, Shi HY, Tang W, et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease. J Crohns Colitis. 2016; 10:1224–1236.
Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011;106(11):1889-1897. doi: 10.1038/ajg.2011.271.
Cohen-Mekelburg S, Waljee AK. Inflammatory Bowel Disease in the Older Adult. Clin Geriatr Med. 2021;37(1):185-195. doi: 10.1016/j.cger.2020.08.013.
Sturm A, Maaser C, Mendall M, Karagiannis D, Karatzas P, Ipenburg N et al. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis. 2017;11(3):263-273. doi: 10.1093/ecco-jcc/jjw188.
Ahmed O, Nguyen G. Therapeutic challenges of managing inflammatory bowel disease in the elderly patient. Expert Rev Gastroenterol Hepatol. 2016;10(9):1005-10. doi: 10.1080/17474124.2016.1179579.
Ananthakrishnan AN. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2013;9(6):367-374.
Shung D, Abraham B, Sellin J, Hou J. Medical and Surgical Complications of Inflammatory Bowel Disease in the Elderly: A Systematic Review. Dig Dis Sci. 2015; 60, 1132–1140. doi: 10.1007/s10620-014-3462-2
Greuter T, Manser C, Pittet V, Vavricka SR, Biedermann L. Gender Differences in Inflammatory Bowel Disease. Digestion. 2020;101 Suppl 1:98-104. doi: 10.1159/000504701.
Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis. 2011; 5:5–13
Norgard BM, Nielsen J, Fonager K, Kjeldsen J, Jacobsen BA, Qvist N. The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data. J Crohns Colitis. 2014; 8(10):1274-80. doi: 10.1016/j.crohns.2014.03.006
Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014; 63:423–432
Everhov A, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, Söderling J et al. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology. 2018;154(3):518-528.e15. doi: 10.1053/j.gastro.2017.10.034
Simian D, Estay C, Kronberg U, Yarur A, Castro M Lubascher J et al. Enfermedad inflamatoria intestinal en pacientes mayores de 60 años: ¿es una enfermedad diferente?. Rev med Chile. 2015; 143(6): 689-696.
Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014;8(11):1351-61. doi: 10.1016/j.crohns.2014.05.006.
Kedia S, Limdi JK, Ahuja V. Management of inflammatory bowel disease in older persons: evolving paradigms. Intest Res. 2018;16(2):194-208. doi: 10.5217/ir.2018.16.2.194.
Calderón M, Minckas N, Nuñez S, Ciapponi A. Inflammatory Bowel Disease in Latin America: A Systematic Review. Value Health Reg Issues. 2018; 17:126-134. doi: 10.1016/j.vhri.2018.03.010.
Harper PC, McAuliffe TL, Beeken WL. Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med. 1986;146(4):753-5
Zammarchi I, Lanzarotto F, Cannatelli R, Munari F, Benini F, Pozzi A, Lanzini A, Ricci C. Elderly-onset vs adult-onset ulcerative colitis: a different natural history? BMC Gastroenterol. 2020; 20:147.
Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther. 2016; 7(1):51-65.
Wagtmans MJ, Verspaget HW, Lamers CB, Van Hogezand RA. Crohn’s disease in the elderly: a comparison with young adults. J Clin Gastroenterol. 1998; 27: 129–133
Rozich JJ, Dulai PS, Fumery M, Sandborn WJ, Singh S. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies. Clin Gastroenterol Hepatol. 2020;18(11):2437-2447.
Mañosa M, Calafat M, de Francisco R, García C, Casanova MJ, Huelín P et al. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study. Aliment Pharmacol Ther. 2018;47(5):605-614
Mak J, Lok H, Wong K, Cheng TY, Yip T, Leung WK et al. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry. J Crohns Colitis. 2021;15(3):401-408.
Connelly TM, Berg AS, Harris L 3rd, Brinton D, Deiling S, Koltun WA. Genetic determinants associated with early age of diagnosis of IBD. Dis Colon Rectum. 2015;58(3):321-7. doi: 10.1097/DCR.0000000000000274.
Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther. 2014;39(5):459-77. doi: 10.1111/apt.12616.
Taleban S, Colombel JF, Mohler MJ, Fain MJ. Inflammatory bowel disease and the elderly: a review. J Crohns Colitis. 2015;9(6):507-15. doi: 10.1093/ecco-jcc/jjv059.
Keyashian K, Dehghan M, Sceats L, Kin C, Limketkai BN, Park KT. Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States. Inflamm Bowel Dis. 2019;25(12):1983-1989. doi: 10.1093/ibd/izz092
Matsumoto S, Miyatani H, Yoshida Y. Ulcerative colitis: comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Dig Dis Sci. 2013 ;58(5):1306-12. doi: 10.1007/s10620-012-2517-5
Saad AM, Czul F, Sakuraba A, Rubin DT, Cohen RD. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease. Inflamm Bowel Dis. 2016 ;22(5):1027-31. doi: 10.1097/MIB.0000000000000732
Juneja M, Baidoo L, Schwartz MB, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57(9):2408-2415
Gonçalves TC, Dias de Castro F, Machado JF, Moreira MJ, Rosa B, Cotter J. Impact of the age of diagnosis on the natural history of ulcerative colitis. Rev Esp Enferm Dig. 2015;107(10):614-21. doi: 10.17235/reed.2015.3736/2015
Lin WC, Chang CW, Shih SC, Wang HY, Hsu TC, Chu CH. The Clinical Features of Elderly-Onset Ulcerative Colitis. J Intern Med Taiwan 2015; 26:196-205.
Ananthakrishnan AN, Nguyen GC, Bernstein CN. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review.Gastroenterology. 2021;160(1):445-451. doi:10.1053/j.gastro.2020.08.060
Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7
Abbas AM, Almukhtar RM, Loftus EV Jr, Lichtenstein GR, Khan N. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Am J Gastroenterol. 2014;109(11):1781-93. doi: 10.1038/ajg.2014.298
Lobatón T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42(4):441-51. doi: 10.1111/apt.13294
Jong M, Smits L,Van Ruijven B, De Broeder N, Russel M, Römkens T et al. Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients, Journal of Crohn's and Colitis. 2020; 14 (7):888–895
Ha CY, Katz S. Clinical outcomes and management of inflammatory bowel disease in the older patient. Curr Gastroenterol Rep. 2013;15(2):310. doi: 10.1007/s11894-012-0310-4
Gower-Rousseau C, Vasseur F, Fumery M, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013;45 (2):89–94.
Parian A, Ha CY. Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(6):1392-400. doi: 10.1097/MIB.0000000000000391.
Fries W, Viola A, Manetti N, Frankovic I, Pugliese D, Monterubbianesi R et al. Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study". Dig Liver Dis. 2017;49(1):17-23
Vieujeun S, Bénédicte C, Jairath V, Benetos A, Danese S, Louis E et al. Is it time to include older adults in inflammatory bowel disease trials? A call for action. The Lancet. 2022; 3 (5): e356-e366
Hruz P, Juillerat P, Kullak-Ublick GA, Schoepfer AM, Mantzaris GJ, Rogler G. Management of the Elderly Inflammatory Bowel Disease Patient. Digestion. 2020;14: 1-15.
Kochar B, Orkaby AR, Ananthakrishnan AN, Ritchie CS. Frailty in inflammatory bowel diseases: an emerging concept. Therap Adv Gastroenterol. 2021; 14:17562848211025474. doi: 10.1177/17562848211025474
Nguyen GC, Bernstein CN, Benchimol EI. Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study. Inflamm Bowel Dis. 2017;23(2):218-223.
Arnott I, Rogler G, Halfvarson J. The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future Perspectives. Inflamm Intest Dis. 2018 Jul;2(4):189-199. doi: 10.1159/000490053.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista de Gastroenterología del Perú
This work is licensed under a Creative Commons Attribution 4.0 International License.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
2022 